Syneos Health [SYENS] vs Azelis Group NV [AZE] Detailed Stock Comparison

Syneos Health, Inc.

EURONEXT
Loading...

Azelis Group NV

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syneos Health, Inc. wins in 6 metrics, Azelis Group NV wins in 12 metrics, with 0 ties. Azelis Group NV appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Syneos Health, Inc. Azelis Group NV Better
P/E Ratio (TTM) 377.86 22.61 Azelis Group NV
Price-to-Book Ratio 0.94 0.94 Azelis Group NV
Debt-to-Equity Ratio 48.61 69.00 Syneos Health, Inc.
PEG Ratio 28.45 12.25 Azelis Group NV
EV/EBITDA 6.44 10.30 Syneos Health, Inc.
Profit Margin (TTM) -1.04% 2.71% Azelis Group NV
Operating Margin (TTM) 4.55% 6.87% Azelis Group NV
EBITDA Margin (TTM) 4.55% 6.87% Azelis Group NV
Return on Equity -1.25% 4.03% Azelis Group NV
Return on Assets (TTM) 2.60% 3.65% Azelis Group NV
Free Cash Flow (TTM) $243.00M $396.76M Azelis Group NV
Dividend Yield N/A 3.25% N/A
1-Year Return -0.44% -32.40% Syneos Health, Inc.
Price-to-Sales Ratio (TTM) 0.96 0.62 Azelis Group NV
Enterprise Value $7.75B $4.16B Syneos Health, Inc.
EV/Revenue Ratio 1.30 1.01 Azelis Group NV
Gross Profit Margin (TTM) 27.96% N/A N/A
Revenue per Share (TTM) $58 $17 Syneos Health, Inc.
Earnings per Share (Diluted) $-0.85 $0.46 Azelis Group NV
Beta (Stock Volatility) 0.13 0.37 Syneos Health, Inc.

Syneos Health, Inc. vs Azelis Group NV Stock Performance Analysis

Loading Price Chart...

SYENS
AZE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syneos Health, Inc.-2.45%0.15%19.51%32.95%-1.05%-3.18%
Azelis Group NV-0.96%3.01%-9.52%34.07%14.88%9.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syneos Health, Inc.-0.44%-28.89%-28.89%-28.89%-28.89%-28.89%
Azelis Group NV-32.40%-58.89%-64.82%-64.82%-64.82%-64.82%

Performance & Financial Health Analysis: Syneos Health, Inc. vs Azelis Group NV

MetricSYENSAZE
Market Information
Market Cap i€5.71B€2.52B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i144,350538,188
90 Day Avg. Volume i239,444649,936
Last Close€67.70€10.27
52 Week Range€41.76 - €82.12€6.88 - €15.02
% from 52W High-17.56%-31.62%
All-Time High€109.90 (Dec 11, 2023)€29.90 (Sep 13, 2021)
% from All-Time High-38.40%-65.65%
Growth Metrics
Quarterly Revenue Growth-0.17%-0.06%
Quarterly Earnings Growth-0.17%-0.68%
Financial Health
Profit Margin (TTM) i-0.01%0.03%
Operating Margin (TTM) i0.05%0.07%
Return on Equity (TTM) i-0.01%0.04%
Debt to Equity (MRQ) i48.6169.00
Cash & Liquidity
Book Value per Share (MRQ)€59.38€11.07
Cash per Share (MRQ)€9.34€1.08
Operating Cash Flow (TTM) i€779.00M€421.67M
Levered Free Cash Flow (TTM) i€449.38M€243.33M
Dividends
Last 12-Month Dividend Yield iN/A3.25%
Last 12-Month Dividend iN/A€0.45

Valuation & Enterprise Metrics Analysis: Syneos Health, Inc. vs Azelis Group NV

MetricSYENS (Apr 24, 2026)AZE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i377.8622.61
Forward P/E i13.1012.25
PEG Ratio i28.4512.25
Price to Sales (TTM) i0.960.62
Price to Book (MRQ) i0.940.94
Market Capitalization
Market Capitalization i€5.71B€2.52B
Enterprise Value i€7.75B€4.16B
Enterprise Value Metrics
Enterprise to Revenue i1.301.01
Enterprise to EBITDA i6.4410.30
Risk & Other Metrics
Beta i0.130.37
Book Value per Share (MRQ) i€59.38€11.07

Financial Statements Comparison: Syneos Health, Inc. vs Azelis Group NV

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSYENS (2025)AZE (2025)
Revenue/Sales i5.97B4.13B
Cost of Goods Sold i4.12B3.16B
COGS % of Revenue i69.1%76.6%
Gross Profit i1.85B968.45M
Gross Margin i30.9%23.4%
Research & Development i295.00MN/A
Operating Income (EBIT) i512.00M313.32M
Operating Margin i8.6%7.6%
EBITDA i1.23B397.83M
EBITDA Margin i20.5%9.6%
Pre-Tax Income i42.00M175.23M
Pre-Tax Income % of Revenue i0.7%4.2%
Income Tax i127.00M61.82M
Income Tax % of Revenue i2.1%1.5%
Net Income (Profit) i-60.00M113.41M
Profit Margin i-1.0%2.7%

Balance Sheet & Liquidity Metrics

MetricSYENS (2025)AZE (2025)
Cash & Equivalents i861.00M263.01M
Total Current Assets i3.30B1.39B
Total Current Assets % of Revenue i55.2%33.6%
Total Current Liabilities i1.57B709.79M
Total Current Liabilities % of Revenue i26.4%17.2%
Long-Term Debt i2.86B1.74B
Long-Term Debt % of Revenue i47.9%42.0%
Total Shareholders Equity i6.09B2.72B
Retained Earnings i4.50B989.81M
Retained Earnings % of Revenue i75.3%24.0%
Property, Plant & Equipment i376.00M115.19M

Cash Flow Statement Comparison

MetricSYENS (2025)AZE (2025)
Operating Cash Flow i149.00M336.72M
Operating Cash Flow % of Revenue i2.5%8.1%
Capital Expenditures i-427.00M-24.91M
Free Cash Flow i243.00M396.76M
FCF Margin i4.1%9.6%
Debt Repayment i-678.00M-256.10M
Common Stock Repurchase iN/A-1.14M

Short Interest & Institutional Ownership Analysis

MetricSYENSAZE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i101.95M243.51M
Float Shares i69.17M210.58M
% Held by Insiders i31.39%0.00%
% Held by Institutions i35.17%69.70%
% Held by Public i33.44%30.30%

Dividend Analysis & Yield Comparison: Syneos Health, Inc. vs Azelis Group NV

MetricSYENSAZE
Last 12-Month Dividend iN/A€0.45
Last 12-Month Dividend Yield iN/A3.25%
3-Year Avg Annual Dividend iN/A€0.24
3-Year Avg Dividend Yield iN/A1.44%
3-Year Total Dividends iN/A€0.73
Ex-Dividend DateN/AJun 27, 2025